The Situation:

Liver cancer is a leading cause of cancer deaths worldwide.1 Early detection facilitates a greater chance of survival.2 If detected early, the 5 year survival rate increases from 15% up to 70% with appropriate interventional treatment.3

The Challenge:

Surveillance programs facilitate earlier cancer detection, earlier access to curative treatments and greater patient survival.2 46% of enrolled patients in surveillance programs had significant increases in 5 year survival due to early tumor detection.4

How We Help:

Enhance Liver Cancer Surveillance using FUJIFILM’s AFP-L3 and DCP tests

Contact Us

Please contact us for further inquiries of FUJIFILM's liver biomarkers AFP-L3 and DCP and uTASWako i30 system.

Share this page